SODIUM ISOBUTYLPARABEN

BannedCAS 84930-15-48 regulations across 8 markets

SODIUM ISOBUTYLPARABEN is a cosmetic ingredient classified as Antimicrobial. Also known as CAS 84930-15-4. It is regulated in 8 markets including Indonesia, South Korea, Malaysia.

Also Known As

CAS Number
84930-15-4

Market Overview — 29 Markets

European Union
United Kingdom1
United States
California
Maryland
Washington
Canada
Brazil
South Korea1
Japan
Taiwan
Australia
Singapore1
Malaysia1
Thailand1
Indonesia1
Vietnam1
Philippines1
UAE
Saudi Arabia
Qatar
Oman
Kuwait
Bahrain
Russia
Belarus
Kazakhstan
Armenia
Kyrgyzstan

Detailed Regulations

Europe1 regulation
United KingdomBannedAnnex II #1375
Chemical name
Sodium salt or Salts of Isobutylparaben
CAS
84930-15-4

Source: UK retained EC 1223/2009 Annex II

AmericasNo restrictions

No specific restrictions for SODIUM ISOBUTYLPARABEN in United States, California, Maryland, Washington, Canada, Brazil.

East Asia & Oceania1 regulation
South KoreaRestrictedAnnex restricted #M1108
Chemical name
Sodium Isobutylparaben
Conditions of use
* 배합한도 : ∙ 단일성분일 경우 0.4%(산으로서) ∙ 혼합사용의 경우 0.8%(산으로서)

Source: MFDS Korea Cosmetics Regulation

ASEAN6 regulations
SingaporeBannedAnnex ACD Annex II (Prohibited) #1375
Chemical name
Sodium salt or Salts of Isobutylparaben Exception for Indonesia: include under Annex VI
CAS
84930-15-4

Source: ASEAN Cosmetic Directive (HSA Dec 2025)

MalaysiaBannedAnnex ACD Annex II (Prohibited) #1375
Chemical name
Sodium salt or Salts of Isobutylparaben Exception for Indonesia: include under Annex VI
CAS
84930-15-4

Source: ASEAN Cosmetic Directive (HSA Dec 2025)

ThailandBannedAnnex ACD Annex II (Prohibited) #1375
Chemical name
Sodium salt or Salts of Isobutylparaben Exception for Indonesia: include under Annex VI
CAS
84930-15-4

Source: ASEAN Cosmetic Directive (HSA Dec 2025)

IndonesiaBannedAnnex ACD Annex II (Prohibited) #1375
Chemical name
Sodium salt or Salts of Isobutylparaben Exception for Indonesia: include under Annex VI
CAS
84930-15-4

Source: ASEAN Cosmetic Directive (HSA Dec 2025)

VietnamBannedAnnex ACD Annex II (Prohibited) #1375
Chemical name
Sodium salt or Salts of Isobutylparaben Exception for Indonesia: include under Annex VI
CAS
84930-15-4

Source: ASEAN Cosmetic Directive (HSA Dec 2025)

PhilippinesBannedAnnex ACD Annex II (Prohibited) #1375
Chemical name
Sodium salt or Salts of Isobutylparaben Exception for Indonesia: include under Annex VI
CAS
84930-15-4

Source: ASEAN Cosmetic Directive (HSA Dec 2025)

GCCNo restrictions

No specific restrictions for SODIUM ISOBUTYLPARABEN in UAE, Saudi Arabia, Qatar, Oman, Kuwait, Bahrain.

EAEUNo restrictions

No specific restrictions for SODIUM ISOBUTYLPARABEN in Russia, Belarus, Kazakhstan, Armenia, Kyrgyzstan.

Frequently Asked Questions

Is SODIUM ISOBUTYLPARABEN banned in any country?

Yes, SODIUM ISOBUTYLPARABEN is banned in Indonesia, Malaysia, Philippines, Singapore, Thailand, United Kingdom, Vietnam. Always check current regulations before formulating products for these markets.

What are the restrictions on SODIUM ISOBUTYLPARABEN in cosmetics?

SODIUM ISOBUTYLPARABEN is restricted or has conditions of use in South Korea. Restrictions may include maximum concentration limits, product type limitations, or mandatory labeling requirements. See the detailed regulations above for specifics.

Can I use SODIUM ISOBUTYLPARABEN in cosmetics?

SODIUM ISOBUTYLPARABEN is regulated in 8 markets. It is banned in Indonesia, Malaysia, Philippines, Singapore, Thailand, United Kingdom, Vietnam. It has restrictions in South Korea. Use Formpli's free screening tool to check your full ingredient list against all 26 markets at once.

Screen SODIUM ISOBUTYLPARABEN with your full formula

Paste your entire ingredient list and get a compliance report across 26 markets — free, no signup.

Check Ingredients Free

This information is for reference only and does not constitute legal or regulatory advice. Regulations change — always verify with official sources and consult a regulatory specialist before exporting cosmetic products. Data sourced from EU COSING, US FDA, Health Canada, MHLW Japan, MFDS Korea, ASEAN ACD, GCC SFDA, TGA Australia, ANVISA Brazil, EAEU TR CU, and Taiwan TFDA.